TELARIA Trademark

Trademark Overview


On Friday, February 17, 2023, a trademark application was filed for TELARIA with the United States Patent and Trademark Office. The USPTO has given the TELARIA trademark a serial number of 97799569. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, March 7, 2024. This trademark is owned by Replay Holdings, Inc.. The TELARIA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of treatments for skin disorders; scientific testing, inspection, research, and development of pharmaceutical preparations for the treatment of skin disorders; scientific research and development of treatment for Epidermolysis Bullosa
telaria

General Information


Serial Number97799569
Word MarkTELARIA
Filing DateFriday, February 17, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, March 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesScientific research and development; research and development of new products in the pharmaceutical and biotechnology fields; research and development of new technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; scientific testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of treatments for skin disorders; scientific testing, inspection, research, and development of pharmaceutical preparations for the treatment of skin disorders; scientific research and development of treatment for Epidermolysis Bullosa

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 7, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameReplay Holdings, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameReplay Holdings, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Tuesday, February 21, 2023NEW APPLICATION ENTERED
Tuesday, March 7, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 20, 2023ASSIGNED TO EXAMINER
Tuesday, April 4, 2023NON-FINAL ACTION WRITTEN
Tuesday, April 4, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 15, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, March 7, 2024SOU TEAS EXTENSION RECEIVED
Thursday, March 7, 2024SOU EXTENSION 1 FILED
Thursday, March 7, 2024SOU EXTENSION 1 GRANTED
Friday, March 8, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED